Industry Collaborations

The PCPGM, working with the Partners Research, Ventures and Licensing Business Development team, establishes strategic alliances with industry to support innovative research and advance the translation of science from bench to bedside. The PCPGM has formed alliances with the following entities:

Affymetrix is a pioneer in creating breakthrough tools that are driving the genomic revolution. By applying the principles of semiconductor technology to the life sciences, Affymetrix develops and commercializes systems that enable scientists to improve quality of life.

A press release covering the alliance between Affymetrix and Partners HealthCare can be found here at Affymetrix’s Investor Relations website.
HP is a technology solutions provider to consumers, businesses and institutions globally. The company’s offerings span IT infrastructure, personal computing and access devices, global services and imaging and printing for consumers, enterprises and small and medium businesses.

The official press release covering the alliance established in 2003 can be found here in HP’s Newsroom. A PDF case study on the alliance can be found here at
Agilent provides core electronic and bio-analytical measurement tools to advance the electronics, communications, life science research, environmental and petrochemical industries.
Millennium Pharmaceuticals, Inc. is a biopharmaceutical company focused on applying its comprehensive and integrated science and technology platform to discover and accelerate the development of drugs and predictive medicine products.
Thermo Electron Corporation is a global technology company serving multiple markets, including the life sciences, telecommunications, food and beverage, chemical, and oil and gas industries, with instrumentation, information-management software, and worldwide service for a range of applications.
Beckman Coulter simplifies, automates and innovates genomics processes, enabling scientists to more readily access genomic information with the goal of identifying new markers of biological, diagnostic and therapeutic interest. We provide complete solutions for gene expression analysis, SNP genotyping, automated nucleic acid sample preparation, DNA sequencing, fragment analysis and molecular diagnostics.
AutoGenomics, Inc. developed one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious diseases, cancer and pharmacogenetics.